Investors & Media

Corporate Profile

Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.

 


Recent Financial Filings

Filing date Form Filing Group
EFFECT
Other
4
3,4,5
3
3,4,5

Stock Information

AURA BIOSCIENCES


April 15, 2024 5:55 AM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.